Breaking News: Vyant Bio Reschedules Investor Conference Call and Webcast for Q2 and First Half of 2022!
Vyant Bio Announces Rescheduled Investor Conference Call and Web… CHERRY HILL, N.J., Aug. 19, 2022 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models…